Drug essentials. Small molecule multitargeted TKI therapy.
Boston Medical Center, Boston, Massachusetts, USA.
Gail M
GM
Wilkes
D001557:Benzenesulfonates / Q000494:pharmacology*; D004347:Drug Interactions; D006801:Humans; D007211:Indoles / Q000494:pharmacology*; D009536:Niacinamide / Q000031:analogs & derivatives; D010353:Patient Education as Topic; D010671:Phenylurea Compounds; D047428:Protein Kinase Inhibitors / Q000494:pharmacology*; D011725:Pyridines / Q000494:pharmacology*; D011758:Pyrroles / Q000494:pharmacology*; D040262:Receptors, Vascular Endothelial Growth Factor / Q000037:antagonists & inhibitors; D000077157:Sorafenib; D000077210:Sunitinib
D001557:Benzenesulfonates; D007211:Indoles; D010671:Phenylurea Compounds; D047428:Protein Kinase Inhibitors; D011725:Pyridines; D011758:Pyrroles; D009536:Niacinamide; D000077157:Sorafenib; D040262:Receptors, Vascular Endothelial Growth Factor; D000077210:Sunitinib